Autologous blood or platelet-rich plasma injections
Platelet-rich plasma (PRP) and whole blood injections are treatments that have been utilized for a variety of healing applications in sports medicine and orthopedic medicine.
Status: Decision completed
Decision summary
Autologous blood and platelet-rich plasma are not covered for any indications.
Documentation
| Type | Materials |
|---|---|
| Assessment (2023) | |
| Assessment (2016) |
Assessment timeline
- Draft key questions published: October 13, 2022
- Public comment period: October 13 to 27, 2022
- Final key questions published: November 29, 2022
- Draft report published: May 11, 2023
- Public comment period: May 11 to June 12, 2023
- Final report published: June 26, 2023
- HTCC public meeting: July 21, 2023
- Draft findings and decision published: July 27, 2023
- Public comment period: July 27 to August 10, 2023
- Final findings and decision published: November 20, 2023
All future dates are estimates and subject to change.